Table 2 Risk factors for sepsis

Number

71

213

 Age > 65 years

35 (49.3 %)

92 (43.2 %)

1.34 (0.74, 2.40)

0.33

 Hospital employee

5 (7.0 %)

13 (6.1 %)

1.16 (0.41, 3.33)

0.78

 Autoimmune condition

0 (0 %)

10 (4.5 %)

Undefined

ND

 Immunosuppression

1 (1.4 %)

3 (1.4 %)

1.00 (0.08, 11.93)

1.00

 COPD

2 (2.8 %)

4 (1.9 %

1.50 (0.27, 8.19)

0.64

 Heart valve replacement

3 (4.2 %)

3 (1.4 %)

3.0 (0.61, 14.86)

0.18

 Benign prostate enlargement

14 (19.7 %)

41 (19.2)

1.24 (0.62, 2.43)

0.54

 Diabetes

10 (14.1 %)

23 (10.8 %)

1.35 (0.61, 2.96)

0.46

 Recent travel

13 (18.3 %)

7 (3.2 %)

5.40 (1.61, 18.09)

0.01

 Recent antimicrobial use

7 (9.8 %)

3 (1.4 %)

9.59 (1.97, 46.62)

0.01

 Recent hospitalisation

1 (1.4 %)

0 (0.0 %)

Undefined

ND

 Use of FQ prophylaxis

70 (98.6 %)

213 (100.0 %)

Undefined

ND

 Duration of FQ prophylaxis <7 days

10 (14.1 %)

44 (20.7 %)

1.72 (0.71, 4.20)

0.23

 Use of aminoglycoside prophylaxis

19 (26.8 %)

43 (20.2 %)

1.85 (0.81, 4.24)

0.14

 Use of a penicillin as prophylaxis

19 (26.8 %)

76 (35.7 %)

0.42 (0.18, 0.98)

0.05

 Use of carbapenem as prophylaxis

0

21 (9.8 %)

Undefined

ND

 Previous biopsy

12 (16.9 %)

36 (16.9 %)

1.29 (0.62, 2.70)

0.50

 Previous biopsy within 3 years

11 (15.5 %)

26 (12.2 %)

1.31 (0.61, 2.83)

0.48

 Urinary catheter

0 (0 %)

0 (0 %)

Undefined

ND

 Preoperative urine culture

1 (1.4 %)

0 (0 %)

Undefined

ND

 Use of enema

31 (43.6 %)

110 (51.6 %)

0.71 (0.30, 1.69)

0.44

 Prostate volume >30 mL

53 (74.6 %)

174 (81.7 %)

1.38 (0.64, 2.93)

0.41

 PSA > 4 mmol

55 (77.4 %)

168 (78.8 %)

Undefined

ND

 Number of biopsy cores >12

46 (64.8 %)

156 (73.2 %)

0.37 (0.14, 0.95)

0.04

 Prostate cancer

42 (59.2 %)

123 (57.7 %)

1.15 (0.63, 2.07)

0.65